Search
Showing results for "1"
Research
Subcutaneous infusion of high-dose benzathine penicillin G is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: a phase 1 open-label population pharmacokinetic studySince 1955, the recommended strategy for rheumatic heart disease secondary prophylaxis has been benzathine penicillin G injections administered intramuscularly every 4 weeks. Due to dosing frequency, pain, and programmatic challenges, adherence is suboptimal. It has previously been demonstrated that BPG delivered subcutaneously at a standard dose is safe and tolerable and has favorable pharmacokinetics, setting the scene for improved regimens with less frequent administration.
News & Events
Coronavirus and children with T1DOur co-director Professor Liz Davis spoke to JDRF Australia to answer COVID-19 and type 1 diabetes questions.
News & Events
Aveni awarded a JDRF fellowshipCongratulations to Children’s Diabetes Centre’s Dr Aveni Haynes on being awarded a JDRF Postdoctoral Fellowship to inform type 1 diabetes prevention strategies by investigating early blood glucose abnormalities in at-risk children.
Research
Environmental (Perinatal) risk factors of ADHD in a sibling control design studyCitation: Ibilola O, Silva D. Environmental (Perinatal) risk factors of ADHD in a sibling control design study. Open Access Journal of Behavioural
Research
Tourette SyndromeOccurring in 1% of school-aged children, Tourette syndrome is a neurodevelopmental disorder characterised by uncontrollable movements and vocalisations known as tics.
Research
Prevalence and characteristics of paediatric X-linked hypophosphataemia in Australia and New Zealand: Results from the Australian and the New Zealand Paediatric Surveillance Units surveyX-linked hypophosphataemia (XLH) is the most common heritable form of rickets. Prevalence data varies across the literature between 1 in 20,000 and 1 in 200,000 per population.
News & Events
Diabetes stigma studyThe aim of this study is to explore the experience of stigma in adolescents with type 1 diabetes and its association with diabetes self-management and glycaemic control.
A new series of educational videos about managing Type 1 Diabetes and its challenges
News & Events
Would you like to have a mentor?Are you a parent of a child with Type 1 Diabetes who could benefit from having a mentor.... someone who knows what you are going through?
Research
A phase IIIB, randomized, controlled, observer-blind study to evaluate safety and immunogenicity of GSK’s meningococcal ABCWY vaccine when administered in healthy adolescents and adults, previously primed with meningococcal ACWY vaccine (BOOST)Investigator: Peter Richmond Project description GSK is conducting a research study to evaluate its investigational, pentavalentmeningococcal vaccine